August 2026
M	T	W	T	F	S	S
	1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Eloïse Laouenan Presents the Results of HEMOTHEPP-CHU Brest-GETBO Prospective Study

Eloïse Laouenan/LinkedIn

Dec 7, 2025, 16:30

Eloïse Laouenan Presents the Results of HEMOTHEPP-CHU Brest-GETBO Prospective Study

Eloïse Laouenan, PhD student in Life and Health Sciences, INSERM, shared on LinkedIn:

”Thanks to the CNGOF and the Pari(s) Santé Femmes congress for this opportunity to present the results of the epidemiology of VTE in the HEMOTHEPP/CHU Brest/GETBO prospective multicenter cohort study (20,238 unselected pregnant women included at delivery, followed 3 months).

Upcoming publication…

– High incidence of postpartum VTE
– Under-prescription of thromboprophylaxis
– Half of VTEs after 7 days postpartum
– High incidence in women at intermediate risk, with or without thromboprophylaxis

VTE risk assessment +++

Perspective: MUM-VTE CHU Brest/GETBO equals multicenter randomized controlled trial (F-CRIN INNOVTE) to evaluate the efficacy and safety of postpartum thromboprophylaxis in women at intermediate risk.

Thanks to all the patients and investigators.

Personal thanks to my team at Service de gynécologie obstétrique et médecine de la reproduction – CHU Brest !!!

Thanks for the photo and support!”

Eloïse Laouenan Presents the Results of HEMOTHEPP-CHU Brest-GETBO Prospective Study